Skip to main content

Table 2 Five-year relative survival rate, by SEER stage and histologic subtype

From: Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

 

2005–2009 (n = 6317)

2010–2014 (n = 7960)

p-value

Early stagea

81.5

86.3

<.0001

 Serous carcinoma

77.7

84.1

<.0001

 Mucinous carcinoma

87.6

88.6

0.379

 Endometrioid carcinoma

88.5

93.6

0.047

 Clear cell carcinoma

86.4

87.4

0.673

Distant stage

38.7

43.9

<.0001

 Serous carcinoma

44.1

49.5

<.0001

 Mucinous carcinoma

30.2

31.5

0.247

 Endometrioid carcinoma

50.3

60.1

0.752

 Clear cell carcinoma

38.0

22.5

0.012

  1. SEER Surveillance, Epidemiology, and End Results
  2. aEarly stage: local + regional